Primary Record
rebamipide
- In stock
- 1,641 g
- Purity
- 99.2 %
- CAS
- 90098-04-7
Compound Identifiers & Properties
- CAS
- 90098-04-7
- PubChem CID
- 5042
- SMILES
- C1=CC=C2C(=C1)C(=CC(=O)N2)CC(C(=O)O)NC(=O)C3=CC=C(C=C3)Cl
- Canonical SMILES
- O=C(NC(Cc1cc(=O)[nH]c2ccccc12)C(=O)O)c1ccc(Cl)cc1
Names & Synonyms
- rebamipide
- Proamipide
- Mucosta
- 90098-04-7
- Rebamipida
- Rebator
- Rebamipidum
- Pramipide
- null
- Rebamipide OD
- Rebamipide-d4
- DisperseRed72
- Rebamipide hydrate
- OPC-12759
- Rebamipide [INN:JAN]
- (R)-Methyglycidate
- Mucosta (TN)
- Rebamipidum [INN-Latin]
- REBAPIMIDE
- Rebamipida [INN-Spanish]
- 111911-87-6
- C19H15ClN2O4
- REBAMIPIDE [MI]
- DTXSID8045937
- OPC12759;Proamipide
- AC1L1JHF
- REBAMIPIDE [INN]
- REBAMIPIDE [JAN]
- rebamipide, (+)-isomer
- rebamipide, (-)-isomer
- RefChem:878997
- Spectrum2_000039
- Spectrum3_001959
- CCRIS 3585
- LR583V32ZR
- UNII-LR583V32ZR
- OPC 12759
- D03BQP
- Rebamipide (JP17/INN)
- ALLWOAVDORUJLA-UHFFFAOYSA-N
- NSC-758955
- REBAMIPIDE [WHO-DD]
- MFCD00866895
- BSPBio_003559
- DTXCID6025937
- GTPL871
- MLS006011883
- SCHEMBL221527
- SPECTRUM1505310
- SPBio_000137
- orb1308173
- QUI103
- Rebamipide - Bio-X trade mark
- CHEMBL1697771
- SCHEMBL28009835
- CHEBI:93814
- CTK8B3342
- ERK5-7A13
- KBio3_002880
- KS-00000SHL
- A02BX14
- AOB5606
- CID5042
- OPC-759
- GLXC-06575
- HMS1922B20
- HMS2090L13
- HMS3655L11
- HMS3714A15
- HMS5080L17
- Pharmakon1600-01505310
- C19-H15-Cl-N2-O4
- BCP07230
- CID:5042
- HY-B0360
- Tox21_111460
- ANW-42341
- BBL011328
- CCG-39619
- CR0013
- EBC-17077
- MFCD11114396
- NCGC00095161-01
- NSC758955
- s2032
- STK577121
- STL146407
- AKOS005501649
- AKOS005721106
- Tox21_111460_1
- 2-[(4-chlorobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
- AC-6841
- AC-7588
- AN-9620
- CS-2416
- CS-O-30754
- DB11656
- FC15908
- NSC 758955
- NCGC00095161-02
- NCGC00095161-03
- NCGC00095161-04
- NCGC00095161-05
- NCGC00095161-15
- 139344-42-6
- 2-(4-Chlorobenzoylamino)-3-(1,2-dihydro-2-oxo-4-quinolyl)propionic acid
- AK316145
- AN-35058
- BC164330
- SC-15936
- SID:53787206
- SMR003309276
- SY057250
- VS-02924
- SBI-0207054.P001
- AB0073108
- AB1009629
- CAS-90098-04-7
- J227.452C
- LS-142127
- LS-142128
- FT-0630971
- FT-0655225
- R0085
- SW199113-2
- 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
- D01121
- AB01275518-01
- AB01275518_02
- AB01275518_03
- 911R876
- A802443
- A843443
- A900081
- C052785
- EN300-19651969
- F300998
- SR-05000001520
- 2-(4-chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid
- 2-[[(4-chlorophenyl)-oxomethyl]amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
- I14-0511
- Q7301602
- SR-05000001520-1
- SR-05000001520-2
- SR-05000001520-3
- 2-[(4-chloro-2,3,5,6-tetradeuteriobenzoyl)amino]-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
- BRD-A15909516-001-02-5
- BRD-A15909516-001-03-3
- BRD-A15909516-001-06-6
- BRD-A15909516-001-07-4
- (+-)-2-(4-Chlorobenzoylamino)-3-(2(1H)-quinolinon-4-yl)propionic acid
- 2-(4-Chlorobenzamido)-3-[2(1H)-quinolinon-4-yl]propionic Acid
- Z2289798874
- (+-)-1,2-Dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-4-quinolinepropanoic acid
- 2-[(4-chlorobenzoyl)amino]-3-(2-hydroxyquinolin-4-yl)propanoic acid
- 2-[(4-chlorophenyl)formamido]-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
- B0084-100251
- (+-)-alpha-(p-Chlorobenzamido)-1,2-dihydro-2-oxo-4-quinolinepropionic acid
- 2-(4-chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propionic acid
- 2-(4-chlorobenzoylamino)-3-(2-quinolon-4-yl)propionic acid
- 4-Quinolinepropanoicacid, a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-
- alpha-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid
- (+-)-alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanic acid
- 2-(4-chlorobenzoylamino)-3-[2(1h)-quinolinon-4-yl] propionic acid
- 2-(4-chlorobenzoylamino)-3-[2(1H)-quinolinon-4-yl]propionic acid
- 4-Quinolinepropanic acid, alpha-((4-chlorobenzoyl)amino)-1,2-dihydro-2-oxo-, (+-)-
- 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-, (+-)-
- N-(4-Chlorobenzoyl)-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine
- N-[(4-chlorophenyl)carbonyl]-3-(2-hydroxyquinolin-4-yl)alanine
- |A-[(4-Chlorobenzoyl)-amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic Acid
- 111911-90-1
- 2-((4-chlorobenzoyl)amino)-3-(2-oxo-1H-quinolin-4-yl)propanoic acid
- 2-(4-Chloro-benzoylamino)-3-(2-hydroxy-quinolin-4-yl)-propionic acid
- 2-(4-Chlorobenzamido)-3-(2-oxo-1,2-dihydro-4-quinolyl)propanoic Acid
- 2-(4-chlorobenzamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoicacid
- 4-Quinolinepropanoic acid, |A-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-
- 4-Quinolinepropanoicacid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-
- alpha-((4-Chlorobenzoyl)amino)-1,2-dihydro-2-oxo-4-quinolinepropanoic Acid
- N-[(4-chlorophenyl)carbonyl]-3-(2-oxo-1,2-dihydroquinolin-4-yl)alanine
- (+/-)-.ALPHA.-(P-CHLOROBENZAMIDO)-1,2-DIHYDRO-2-OXO-4-QUINOLINEPROPIONIC ACID
- (+/-)-2-(4-CHLOROBENZOYLAMINO)-3-(2(1H)-QUINOLINON-4-YL)-PROPIONIC ACID
- (2RS)-2-(4-Chlorobenzoylamino)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
- 2-((4-chlorophenyl)formamido)-3-(2-oxo-1,2-dihydroquinolin-4-yl)propanoic acid
- 2-(4-chloro-benzoylamino)-3-(2-oxo-1,2-dihydro-quinolin-4-yl)-propionic acid
- 2-[(4-chlorophenyl)carbonylamino]-3-(2-oxidanylidene-1H-quinolin-4-yl)propanoic acid
- 4-QUINOLINEPROPANOIC ACID, .ALPHA.-((4-CHLOROBENZOYL)AMINO)-1,2-DIHYDRO-2-OXO-
- 4-Quinolinepropanoic acid, 1,2-dihydro-alpha-((4-chlorobenzoyl)amino)-2-oxo-,(+-)-
- 4-Quinolinepropanoic acid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (+/-)-
- 4-Quinolinepropanoic acid,a-[(4-chlorobenzoyl)amino]-1,2-dihydro-2-oxo-, (A+/-)-
- alpha-[(4-Chlorobenzoyl)amino]-1,2-dihydro-2-oxo-4-quinolinepropanoic acid hydrate
- 1219409-06-9
- 815-380-0
- Rebamipide, 99%, Inducer of endogenous prostaglandin and a oxygen-derived free radical scavenger - 25MG 25mg